| GlaxoSmithKline AG - Menveo, Pulver und Lösung (Durchstechflaschen) | | 62502 | | 01 | | Menveo | | Pulver und Lösung (Durchstechflaschen) | | J07AH08 | | Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated | | 30.11.2011 | | |
| | Composition | | I) Vaccinum conjugatum in praeparatio cryodesiccata: oligosaccharida neisseriae meningitidis A 10 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 16.7-33.3 µg, kalii dihydrogenophosphas corresp. kalium 0.098 mg, saccharum, pro vitro.
.
II) Vaccini conjugati in solutio: oligosaccharida neisseriae meningitidis C 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 7.1-12.5 µg, oligosaccharida neisseriae meningitidis W-135 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 3.3-8.3 µg, oligosaccharida neisseriae meningitidis Y 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 5.6-10 µg, natrii chloridum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.885 mg. | | Packungsbestandteile | | I | | | Pulver und Lösung (Durchstechflaschen) | | | | | | | | Active Agent | Dose |
|---|
| Oligosaccharida Neisseriae Meningitidis A | 10 µg |
| | BAG: Active Agent | Dose |
|---|
| Oligosaccharida Neisseriae Meningitidis A | 10 mcg | | Oligosaccharida Neisseriae Meningitidis C | 5 mcg | | Oligosaccharida Neisseriae Meningitidis W135 | 5 mcg | | Oligosaccharida Neisseriae Meningitidis Y | 5 mcg | | Vaccinum Meningitidis Oligosaccharid. A, C, W135, y Conjugatum Crm | |
| | | | Inactive agents | Dose |
|---|
| Conjugatum cum Proteinum Corynebacteriae Diphtheriae crm 197 | 16.7-33.3 µg | | Potassium Dihydrogenophosphate | | | Saccharum | |
| |
| II | | | Pulver und Lösung (Durchstechflaschen) | | | | | | | | Active Agent | Dose |
|---|
| Oligosaccharida Neisseriae Meningitidis C | 5µg / 0.5ml | | Oligosaccharida Neisseriae Meningitidis W135 | 5µg / 0.5ml | | Oligosaccharida Neisseriae Meningitidis Y | 5µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Oligosaccharida Neisseriae Meningitidis A | 10 mcg | | Oligosaccharida Neisseriae Meningitidis C | 5 mcg | | Oligosaccharida Neisseriae Meningitidis W135 | 5 mcg | | Oligosaccharida Neisseriae Meningitidis Y | 5 mcg | | Vaccinum Meningitidis Oligosaccharid. A, C, W135, y Conjugatum Crm | |
| | | | Inactive agents | Dose |
|---|
| Conjugatum cum Proteinum Corynebacteriae Diphtheriae crm 197 | 7.8µg / 0.5ml | | Disodium Phosphate Dihydrate | | | Sodium Chloride | | | Sodium Dihydrogenophosphate Monohydrate | |
| |
| |
|
